Verdiva Bio raised €399M in a Series A round in Jan 2025. The company is based in London, UK. Investors in the round: Forbion, General Atlantic, Lilly Asia Ventures and 4 others. Data as of 6 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
